Background
==========

Inherited retinal degenerations form a diverse spectrum of blinding disorders in humans and other mammals, including a large number of dog breeds \[[@B1]\]. Retinal diseases are inherited as monogenic or complex traits. In the last two decades over 130 genes that cause retinal diseases have been identified \[[@B2]\].

Progressive retinal atrophies (PRA) are the most common retinopathies in dogs and constitute a heterogeneous group of phenotypically similar disorders equivalent to retinitis pigmentosa (RP) in man. PRA, like RP, is primarily a disease of rod photoreceptors, while cone function and structure degenerate secondarily. PRA has been identified and studied in more than 100 breeds and distinct loci primarily responsible for each disorder have been identified in at least 22 different breeds \[[@B1],[@B3]\].

The cone dystrophies comprise a phenotypically heterogeneous group of hereditary retinal degenerations characterized by progressive dysfunction of the photopic (cone-mediated) system. The presenting signs include day blindness, loss of colour vision, reduced central visual acuity and preserved peripheral vision \[[@B4]\]. The cone dystrophies are genetically heterogenous and may be sporadic, autosomal dominant, autosomal recessive or X-linked recessive \[[@B2]\].

Canine cone degeneration is phenotypically similar to human achromatopsia \[[@B5]\]. Identified genes associated with human achromatopsia are the phototransducin genes *GNAT2*(HSA1) \[[@B6]\], the *CNGA3*(HSA2) \[[@B7]\] and the *CNGB3*(HSA8) \[[@B8]\] genes.

Autosomal recessive cone degeneration occurs naturally in Alaskan malamute \[[@B9]\] and German shorthaired pointer (GSP) and is due to different mutations in CNGB3 \[[@B5],[@B10]\]. Sporadic cases is seen in a number of other breeds \[[@B11],[@B12]\].

The cone-rod dystrophies (crd) are characterized by a predominant loss of cone function, with relative preservation of rod function \[[@B13],[@B14]\]. The number of genes or loci currently identified for crd in humans is low, compared to those for RP \[[@B2]\]. Identified genes associated with autosomal recessive inherited crd in man include *ABCA4*\[[@B15],[@B16]\] and *RDH5*\[[@B17]\] in addition to the mapped loci *CORD8*\[[@B18],[@B19]\] and *CORD9*\[[@B20]\]. *ABCA4*and *RDH5*are genes involved in the retinoid cycle, the *CORD8*and *CORD9*loci are yet to be identified. The standard wire haired dachshund (SWHD), the miniature long haired dachshund (MLHD) and the pit bull terrier (PBT) are the only dog breeds to date known to be affected by crd \[[@B21]-[@B23]\].

Canine *ABCA4*has been studied as a candidate gene for cone-rod degeneration in the pit bull terrier, although no mutations were found \[[@B21]\]. Mutations in the *RPGRIP1*gene have been reported to be a cause of Leber congenital amaurosis (LCA) \[[@B24],[@B25]\]. LCA is the earliest and most severe form of all retinal dystrophies responsible for congenital blindness \[[@B26]\]. Mutations causing residual *RPGRIP1*activity may lead to phenotypes such as RP or crd, which are less severe than LCA \[[@B27]\]. In 2003, Hameed et al. (2003) \[[@B28]\] showed evidence that some *RPGRIP1*gene mutations are associated with recessive cone-rod dystrophy. Recently Mellersh et al. (2006) \[[@B22]\] found a mutation in canine *RPGRIP1*associated with autosomal recessive crd in miniature longhaired dachshunds.

A high level of genetic heterogeneity of the disease group is observed and a range of mutations in *RPGRIP1*, *CRX*and *GUCY2D*cause different retinal diseases with different modes of inheritance \[[@B14],[@B27]-[@B34]\].

A resource strain of standard wire haired dachshund displaying day blindness was developed to allow characterization of the phenotype and identification of the causal mutation. Electroretinography (ERG) and clinical studies showed that secondary degeneration of the rods appeared during the progression of the disease of the dogs of the colony, indicating a progressive cone-rod dystrophy (crd) \[[@B23]\]. The disease seems to be inherited in an autosomal recessive manner, and diversity in the age of onset and progression of the retinal degeneration within the group of affected dachshunds is observed.

This study was conducted in parallel with clinical studies \[[@B35]\] and genes known to be involved in human cone degeneration, cone dystrophy and cone-rod dystrophy were evaluated as candidate genes for the day blindness in the SWHD (See Table [1](#T1){ref-type="table"}).

###### 

Overview of the candidate genes

  **Candidate**   **Canine chr**   **Location**          **Annotation**   **Coding for**                                                                             **Disease\***
  --------------- ---------------- --------------------- ---------------- ------------------------------------------------------------------------------------------ ---------------
  CNGB3           CFA29            35896147-35752878     NC_006611        cyclic nucleotide gated channel beta 3                                                     cd
  CNGA3           CFA10            47377091-47357441     NC_006592        cyclic nucleotide gated channel alpha 3                                                    cd
  GNAT2           CFA6             45319301-45327681     NC_006588        guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 2   cd
  ABCA4           CFA6             58112924-58240779     NC_006588        ATP-binding cassette, sub-family A (ABC1), member 4                                        crd
  RDH5            CFA10            3102451-3106432       NC_006592        retinol dehydrogenase 5 (11-cis/9-cis)                                                     crd
  CORD8           CFA9             HSA1q12--24                            unknown                                                                                    crd
  CORD9           CFA29            HSA8p11                                unknown                                                                                    crd
  RPGRIP1         CFA15            21355638-21394395     NC_006597        retinitis pigmentosa GTPase regulator interacting protein 1                                crd
  GUCY2D          CFA5             35838279-35853509     NC_006587        guanylate cyclase 2D, membrane (retina-specific)                                           crd
  CRX             CFA1             111135799-111146903   NC_006583        cone-rod homeobox                                                                          crd

\*cd = cone degeneration and crd = cone-rod-dystrophy

Results
=======

An overview of the studied genes and their location is shown in Table [1](#T1){ref-type="table"}. Studies of segregation of each of the 10 candidate loci and clinical disease in informative parents and offspring revealed a number of new candidate gene allele-disease phenotype combinations (\"recombinants\") in the offspring. The segregation of potential candidate gene alleles was studied in inbred offspring from parents with known disease genotypes. Females where either homozygous affected (= clinical diseased) or carriers (= clinical healthy offspring of affected male). Since the father in these litters usually was homozygous affected, the theoretical phenotype of the offspring would depend on which of the two potential alleles (affected or non-affected) it received from its carrier mother. The most frequently occurring genotype-phenotype combination was counted as the non-recombinants, while any new genotype-phenotype combination, with regard to their parents, was counted as recombinant. Each litter was counted as a separate unit and the recombination frequency were summed over all families. A minimum of 6 recombinants were identified for each of the 10 loci (See Table [2](#T2){ref-type="table"}). This excludes all the candidate genes as the cause of mutation causing the disease. The family is illustrated in Figure [1](#F1){ref-type="fig"}. The genotypes of ABCA4-markers are shown below each individual and show free recombination of ABCA4-variants between affected and unaffected offspring.

###### 

Recombination frequencies between candidate gene loci (microsatellites at locus) and disease

  **Locus**   **no. of informative offspring**   **no. of recombinant offspring**   **Recombination frequency**   **LOD score**
  ----------- ---------------------------------- ---------------------------------- ----------------------------- ---------------
  CNGB3       34                                 11                                 0.32                          0.940
  CNGA3       20                                 7                                  0.35                          0.397
  GNAT2       31                                 6                                  0.19                          2.717
  ABCA4       34                                 11                                 0.32                          0.940
  RDH5        34                                 11                                 0.32                          0.940
  CORD8       25                                 10                                 0.40                          0.219
  CORD9       18                                 5                                  0.28                          0.800
  CRX         24                                 8                                  0.33                          0.590
  GUCY2D      23                                 7                                  0.30                          0.786

![**The informative resource family, consisting of offspring from a single affected male.**The numbers below each individual represent ABCA4 genotypes, and clearly shows the free recombination of marker-alleles compared to disease in the family.](1746-6148-4-23-1){#F1}

Discussion
==========

The large number of retinal genes or loci have been identified and presented at the RetNet™ web page \[[@B2]\], facilitates a candidate gene approach in the study of canine retinal diseases. Human genes with mutations giving similar phenotypes and inheritance patterns to the one found in the affected SWHDs were selected as candidate genes. The preliminary clinical diagnoses for the affected SWHDs suggested that the disease was comparable with human cone degeneration, hence the inclusion of *CNGB3*, *CNGA3*and *GNAT2*, which are associated primarily with cone degeneration. In the initial phase of the study the family material was not sufficient for segregation studies and we therefore sequenced the coding parts of these three genes. No mutations where identified in any of the three genes (methods and results not shown). Continued electrophysiological and clinical studies of the affected dachshunds were conducted in parallel with the genetic studies and revealed secondary continuing degeneration of the rods, indicating a progressive cone-rod dystrophy (crd) \[[@B23]\]. Seven genes reported to be associated with autosomal recessive cone-rod dystrophies (crd) \[[@B2]\], *ABCA4*, *RDH5*, *CORD8*, *CORD9*, *RPGRIP1*, *CRX*and *GUCY2D*were therefore included in the study.

It is important to be aware of the fact that the disease-allele/haplotype present in all dogs in the family arises from inbreeding on one single affected founder (Figure [1](#F1){ref-type="fig"}). The informative markers were selected at the exact position of the candidate genes, most of them less than approximately 0.1 Mb distance. A distance of 0.1 Mb compares to a genetic distance of \~0.1 cM, or 1 recombination per 1000 offspring. The minimum number of detected recombinations in our family (1 recombination per 36 informative offspring) would compare to a recombination frequency/genetic distance of \~2.8 cM or a physical distance of \~2.8 Mb. We would not expect any recombinants if a mutation in any of the candidate genes caused this disease with a simple recessive inheritance. Our results show a minimum of 6 recombinations (GNAT2; 31 informative offspring) or more than 19.3 Mb distance (Table [2](#T2){ref-type="table"}), excluding all the candidate genes as the site of the mutation causing the disease. However, even though the specific candidate genes can be excluded as the cause of the disease because of the high number of recombinations, the chromosomal regions are not necessarily excluded. The clinical findings defining the diseases as a cone-rod dystrophy rather than cone degeneration also support the exclusion of *CNGB3*, *CNGA3*and *GNAT2*. The candidate loci *CORD8*and *CORD9*are not yet mapped and the genes remain to be identified, but the markers typed for these loci are located within 2.8 Mb of the gene and several recombinations exclude these loci as well.

It might be considered likely that crd in MLDH and SWDH was caused by the same mutation, since these two breeds have in part the same genetic background. There are, however, obvious differences in the clinical phenotypes of the disease in the two breeds. One of the most characteristic clinical findings in the SWDH is pinpoint-sized pupils, observed in 60% of the 8-week old, crd-affected puppies. Older crd-affected dogs displayed dilated pupils and delayed pupillary light reflexes (PLRs) when stimulated with a focal light source \[[@B23]\]. This is in contrast to the clinical signs of PBT and MLHD, which include dilated pupils at 7--8 weeks of age for PBT and normal PLRs at 25 weeks of age for MLHD, respectively \[[@B21],[@B34]\]. The differences in clinical signs between the MLHD and the SWHD, support the finding of free recombination between *RPGRIP1*and the disease in the SWHD. This shows that this disease in the SWHDs is a unique animal model for cone-rod dystrophy.

The development of animal models of ocular disease represents an invaluable resource for testing and evaluating treatment strategies relevant to both human and canine disease. Attempts at restoring vision in dogs and human by gene therapy have been made, providing optimism regarding potential for recovery of functional vision \[[@B36]-[@B41]\]. Uncovering the genetic basis of the cone-rod dystrophy in the SWHD may contribute to finding new gene therapy treatments.

The present work has excluded a number of genes as a cause of crd in the SWHD. Research in human and animals continuously identifies new genes that may be associated with crd. In addition to continued studies of a few specific candidate genes, future research will focus on a whole genome scan by linkage studies with polymorphic markers \[[@B42]\] or by SNP-array typing \[[@B43]\]. The development of the canine genotyping array of \~27000 SNPs show that genome-wide association mapping of mendelian traits in dog breeds can be achieved with only \~20 dogs \[[@B44]\]. The use of SNP array technology, followed by fine mapping based on microsatellites and regional gene studies may be the best method to elucidate which gene is involved in this disease.

Conclusion
==========

The genes involved in cone degeneration, *CNGB3*, *CNGA3*and *GNAT2*, and the genes involved in cone-rod dystrophy, *ABCA4*, *RDH5*, *Cord8*, *Cord9*, *RPGRIP1*, *GUCY2D*and *CRX*, were all excluded from being involved in the cone-rod dystrophy described in this family of SWHD. The study provides a number of genetic markers for use in other studies. Further work, based on a whole genome association study will be performed to identify the mutation involved in the disease.

Methods
=======

Animals
-------

Day blindness was diagnosed in two wire haired dachshund littermates, one male and one female, in a litter of four. The parents were phenotypically normal. The male was bred to two unrelated crossbred dogs with no history of previous eye disease and the dogs in the F1 generation were unaffected. A purpose-bred colony was established through back-crossing the male with his daughters, producing both affected and unaffected offspring. The retinal changes were always bilaterally symmetrical and the initial onset was observed from 10 months to 3 years of age. A complete retinal atrophy was evident within the age of 5--6 years.

Clinical diagnosis
------------------

To evaluate vision, all dogs were subjected to behavioral testing (maze test), examination of pupillary light reflexes (PLRs), indirect ophthalmoscopy and bilateral full-field electroretinography (ERG). Light microscopy, electron microscopy and immunohistochemistry were carried out in 22 selected cases at ages 5--304 weeks, in order to confirm the diagnoses \[[@B23]\].

All procedures used in this study adhered to the guidelines of the Norwegian Animal Research Authority (Forsøksdyrutvalget) and to the Association for Research in Vision and Ophthalmology\'s \"Statement for the use of Animals in Ophthalmic Vision and Research\".

Samples
-------

Blood samples were collected into EDTA-coated tubes from all the related dogs in the day blind colony and from two non-affected, unrelated dogs. Genomic DNA was isolated from the blood samples using DNeasy Tissue kit (Qiagen, GmbH, Germany).

The collected DNA samples were subjected to candidate gene screening. All the ten loci were typed by polymorphic markers at these loci in five informative dachshund families comprising 43 dogs -7 parents and 36 offspring (Figure [1](#F1){ref-type="fig"}), to detect recombinants between each of the loci and the disease.

Study of marker-disease segregation in the resource family
----------------------------------------------------------

Genotyping of *CNGB3*was done with two closely linked markers, FH2772 \[[@B45]\] and c29.002 \[[@B46]\], embracing the gene (530 Kb and 350 Kb distance respectively). Markers for genotyping of *CNGA3, GNAT2 ABCA4*, *RDH5*, *CRX*, *GUCY2D*and *RPGRIP1*were identified by searching a sequence of about 200,000 bp, including the gene(s) (gene +/- \~100 000 bp), for various microsatellite motives. FH2370, a marker closely linked to *ABCA4*\[[@B46]\] was also genotyped. For the loci *CORD8*and *CORD9*, 200 000 basepairs surrounding genes at the site of the two loci, respectively *FM05*and *RP1*, were used to identify polymorphic markers. Tetra- and dinucleotide repeat microsatellites with more than ten and nineteen repeats, respectively, were selected. Primers for amplification of selected microsatellites were designed using primer3 \[[@B47]\] (See Table [3](#T3){ref-type="table"}). One primer in each pair was labelled with fluorescein for automated detection in an automated fragment analyzer, ABI3100 Genetic Analyser.

###### 

Primers for amplification of the microsatellites at the exact position of the candidate gene loci

  **Microsatellite**   **Forward primer (5\'-3\')**   **Reverse primer (5\'-3\')**   **Size of PCR-product (bp)**   **Nucleotide repeat**   **Location (bp)**          **Accession number**
  -------------------- ------------------------------ ------------------------------ ------------------------------ ----------------------- -------------------------- ----------------------
  CNGB3-FH2772         CCCAAAGCACATCCTAATTC           GGAGTCTGCTTCTCCCTTTC           168                            di                      Chr29:35405042-35405217    UniSTS 263646
  CNGB3-C29.002        TATTAAATCCCAGTCACCACCC         AGGTCCCAGACCGAGTCC             208                            di                      Chr29:36423257-36423471    UniSTS 262830
  CNGA3-GT19           CCTCCCACTCTCCCCTCTAC           CCAGGGGAGCTTTTACAACA           337                            di                      Chr10:47307640-47307977    BV729091
  CNGA3-GT20           GCAAGCAGTCCCGATTTTTA           TCAGCTTTGGTCATGCACTC           304                            di                      Chr10:47283009-47283313    BV729076
  GNAT2-GAAA16         CCCATGCTTGGTTTAATGCT           GACTGTCCTGCCTTCCATGT           350                            tetra                   Chr6:45194834-45195184     BV729077
  GNAT2-CTT22          CAGCTGGATTCTTCCCATGA           GCCCAAATTGCAAATCCTTA           273                            tri                     Chr6:45461591-45461864     BV729078
  ABCA4-FH2370         CCTGAAAAATAGCTAGATGATGG        GTCTTTACCTGCCTATATAGCTGC       380                            tetra                   Chr6:58367514-58367919     UniSTS 263571
  ABCA4-TTTC16m        GGAATCAGTGGACTCATCCAA          GGGGATTGGACAGTGGTAGA           238                            tetra                   Chr6:58046419-58046656     BV729079
  RDH5-TAGA10          GAAGATGACGATGATGATGAAGA        GCTGAAGGTAGACGCTGGAC           286                            tetra                   Chr10:3068645-3068931      BV729080
  RDH5-GAAA16          CCCTGCTGTGAGGAGTCAGT           AGCCAGATGCAGGACTTGAT           209                            tetra                   Chr10:3002063-3002276      BV729081
  CORD8-FMO5-GAAA12    CCACAAGTTGGGGTTTCAAG           CCCCTCCTCTCTCTCTTTCC           204                            tetra                   Chr9:60070458-60070662     BV729082
  CORD8-FMO5-TTTA10    CCCAGGTGTCCCTATTTTCC           GCTCACTGGGGAGTCTGCT            175                            tetra                   Chr9:60654305-60654480     BV729083
  CORD9-RP1-ATm22      CACTGGATGCACACAGATCC           GGTCCTTGAGAAGGAAGCTG           296                            di                      Chr29:9128657-9128953      BV729084
  CORD9-RP1-TTTC21m    TCCAGTAGGCGTCCTCTGAC           AGTCAATGGAGCCTGCAACT           410                            tetra                   Chr29:9011174-9011583      BV729085
  RPGRIP1-GAAA26       TGTTACCTGTTCCAAAGTTGTTTT       AGTTACAGCCATGGGAATGC           475                            tetra                   Chr15:21287275-21287750    BV729086
  GUCY2D-TTCC15        ACAATGGGCACATCTGTTGA           TTCTCCCTCTGCCTGTGTCT           405                            tetra                   Chr5:35459311-35459716     BV729089
  GUCY2D-GAAA17        CCCCTCTTCTCCACTCTCCT           TCATATTCTTGCCCCAGTCC           444                            tetra                   Chr5:35514793-35515246     BV729090
  CRX-GAAA15m          TGGTCTCACATTCCCACTGA           AGAAGTGGCAGAGCACAGGT           438                            tetra                   Chr1:111096908-111097346   BV729087
  CRX-GT21             ACCAGAACCAAAGGCAGATG           TCAGGGTTGGAGTTTTGAGC           427                            di                      Chr1:111076912-111077339   BV729088

PCR amplification reactions were performed using 83 μM of each primer in a 15 μl reaction containing 1.5 μl DNA prepared as described above, 1× PCR buffer containing 1.5 mM MgCl~2~, 83 μM each of dATP, dCTP, dGTP and dTTP, and 0,33 units Taq DNA polymerase (Qiagen). After an initial denaturation at 95°C for 2 min and 30 sec, samples were amplified for 28 cycles at 95°C for 30 sec, 58°C for 40 sec and 72°C for 50 sec, followed by a final extension of 72°C for 5 min and 30 sec. The sizes of the alleles were estimated with an automated sequencer (ABI PRISM^®^3100 Genetic Analyzer, Applied Biosystems, Foster City, CA, U.S.A.) with software for fragment analysis.
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